NU-RISE

NU-RISE operates in the medical technology sector, specializing in advanced nuclear radiation sensors and equipment for medical, industrial, and research applications. The company was established in 2015 as a spin-off from the University of Aveiro in Portugal and is headquartered in Ílhavo. Its founders include Luís Moutinho, who serves as CEO, Joana Melo, the COO, and Filipe Castro. The founding team's journey began with the challenge of transforming a technological concept into a viable product, a process accelerated through research and development programs in collaboration with the University of Aveiro.

The company's primary business involves the development and manufacturing of radiation detection hardware and adaptive software. Its main clients are healthcare providers, specifically hospitals and clinics that utilize radiotherapy for cancer treatment. NU-RISE's business model is centered on selling its specialized medical devices that enhance the safety and precision of radiation therapy. The firm has successfully secured approximately $3.54 million in funding over several rounds, with key investors including Portugal Ventures, EIT Health, Caixa Capital, and GED Ventures Portugal, to support its growth and international expansion.

NU-RISE's flagship product is a system designed for real-time, in-vivo patient dose tracking during radiotherapy, a critical unmet need in treatments like brachytherapy for prostate, breast, and gynecological cancers. This system empowers clinicians to monitor the radiation dose being delivered to the tumor and surrounding healthy organs as the treatment happens. A key component is its ultrasensitive, high-resolution photonic sensor technology. The ability to make immediate adjustments based on this real-time data allows for adaptive radiotherapy, which can lead to more accurate, personalized, and safer cancer treatments with fewer sessions and reduced side effects. This real-time verification capability represents a significant evolution from conventional methods, which often lack immediate feedback.

Keywords: real-time dosimetry, brachytherapy, radiation sensors, radiotherapy safety, medical devices, in-vivo dose monitoring, oncology technology, adaptive radiotherapy, cancer treatment, nuclear radiation sensors, University of Aveiro spin-off, MedTech, health technology, radiation oncology, patient dose tracking, photonic sensors, brachytherapy solutions, medical equipment, Portugal Ventures, EIT Health